[{"begin": 0, "end": 162, "text": "Fine RL, Gulati AP, Krantz BA, Moss RA, Schreibman S, Tsushima DA, Mowatt KB, Dinnen RD, Mao Y, Stevens PD, Schrope B, Allendorf J, Lee JA, Sherman WH, Chabot JA.", "tokenized_text": "Fine RL , Gulati AP , Krantz BA , Moss RA , Schreibman S , Tsushima DA , Mowatt KB , Dinnen RD , Mao Y , Stevens PD , Schrope B , Allendorf J , Lee JA , Sherman WH , Chabot JA .", "type": "authors", "id": 0}, {"begin": 163, "end": 192, "text": "Capecitabine and temozolomide", "tokenized_text": "Capecitabine and temozolomide", "type": "title", "id": 1}, {"begin": 200, "end": 315, "text": ") for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience", "tokenized_text": ") for metastatic , well - differentiated neuroendocrine cancers : The Pancreas Center at Columbia University experience", "type": "title", "id": 2}, {"begin": 317, "end": 343, "text": "Cancer Chemother Pharmacol", "tokenized_text": "Cancer Chemother Pharmacol", "type": "venue", "id": 3}, {"begin": 345, "end": 349, "text": "2013", "tokenized_text": "2013", "type": "year", "id": 4}]